![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, June 29, 2022 4:11:34 PM
View on a Browser
NATIONAL CONFERENCE
Breaking Barriers in Brain Tumor Treatments
September
9-10
Researchers are uncovering ways to improve treatment responses and the overall quality of life for brain tumor patients.
Join the nation's largest free brain tumor conference for a look at the technology and research pushing the limits of common brain tumor therapies.
Learn about:
? Advances in systemic therapies and devices used to treat gliomas and meningiomas
? Overcoming the blood-brain barrier and treatment resistance
? Advanced radiotherapy techniques to combat cognitive side effects of treatment
View the full program and sign up at no cost!
REGISTER NOW
Have a question?
Contact us at info@abta.org or call (800) 886-2282.
We appreciate our sponsors!
Novocure, an ABTA National Conference sponsor
GT Medical Technologies, an ABTA National Conference sponsor
Servier Pharmaceuticals, an ABTA National Conference Sponsor
Miami Cancer Institute | Baptist Health South Florida, an ABTA National Conference Sponsor
Northwestern Medicine, an ABTA National Conference sponsor
Orbus Therapeutics, an ABTA National Conference sponsor
Ivy Brain Tumor Center, an ABTA National Conference sponsor
Immunomic Therapeutics, an ABTA National Conference sponsor
Medexus Pharma, an ABTA National Conference sponsor
VBI Vaccines, an ABTA National Conference sponsor
Mayo Clinic, an ABTA National Conference sponsor
OncoSynergy, an ABTA National Conference sponsor
SNO, Society of Neuro Oncology, an ABTA National Conference sponsor
YouTube
Copyright © 2022 American Brain Tumor Association. All rights reserved.
American Brain Tumor Association
8550 W. Bryn Mawr Ave., Ste 550
Chicago, IL 60631
Unsubscribe
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM